Literature DB >> 1777947

Tumor necrosis factor (cachectin) in the biology of septic shock syndrome.

K J Tracey1.   

Abstract

The high mortality of septic shock syndrome has prompted extensive investigation into its pathogenesis. Tumor necrosis factor (TNF), a cytokine that is often over-produced during Gram-negative or Gram-positive infection, occupies a critical role in triggering this catastrophic illness. The net effects of TNF are dependent upon its concentration in certain vital tissues, and may be dissociated from the presence of the invading pathogens. Agents that inhibit TNF have been developed; these protect against shock and tissue injury and are currently being investigated in clinical trials of septic shock syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777947

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  20 in total

1.  More on pathogenesis and treatment of septic shock.

Authors:  D Fumarola; S Pece
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

2.  FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis.

Authors:  Kenneth R Feingold; Carl Grunfeld; Josef G Heuer; Akanksha Gupta; Martin Cramer; Tonghai Zhang; Judy K Shigenaga; Sophie M Patzek; Zoe W Chan; Arthur Moser; Holly Bina; Alexei Kharitonenkov
Journal:  Endocrinology       Date:  2012-04-02       Impact factor: 4.736

Review 3.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 4.  Sepsis and septic shock. II. Treatment.

Authors:  J Mayer; R Hajek; J Vorlicek; M Tomiska
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

5.  Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia.

Authors:  H Redl; G Schlag; G R Adolf; B Natmessnig; J Davies
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

6.  Suppressive Effect on Lipopolysaccharide-Induced Proinflammatory Mediators by Citrus aurantium L. in Macrophage RAW 264.7 Cells via NF-κB Signal Pathway.

Authors:  Sang-Rim Kang; Dae-Yong Han; Kwang-Il Park; Hyeon-Soo Park; Yong-Bae Cho; Hu-Jang Lee; Won-Sup Lee; Chung Ho Ryu; Yeong Lae Ha; Do Hoon Lee; Jin A Kim; Gon-Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-21       Impact factor: 2.629

7.  Patient cytokine response in transfusion-associated sepsis.

Authors:  S K McAllister; L A Bland; M J Arduino; S M Aguero; P N Wenger; W R Jarvis
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Alterations of bacterial clearance induced by endotoxin and tumor necrosis factor.

Authors:  T Koch; H P Duncker; R Axt; H G Schiefer; K van Ackern; H Neuhof
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.

Authors:  M Bianchi; P Ulrich; O Bloom; M Meistrell; G A Zimmerman; H Schmidtmayerova; M Bukrinsky; T Donnelley; R Bucala; B Sherry
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

10.  Differential binding of bacterial lipopolysaccharide to bovine peripheral-blood leukocytes.

Authors:  P N Bochsler; J M Maddux; N R Neilsen; D O Slauson
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.